Nan Soon Wong

Tamoxifen metabolism predicts drug concentrations and outcome in premenopausal patients with early breast cancer

Pilar H. Saladores, Thomas E. Mürdter, Diana Eccles et al. · The Pharmacogenomics Journal · 2014 · 198 citations · Full text

Medicine, Oncology, Pharmacology +17

Impact of <i>CYP2D6</i>, <i>CYP3A5</i>, <i>CYP2C9</i> and <i>CYP2C19</i> polymorphisms on tamoxifen pharmacokinetics in Asian breast cancer patients

Joanne Lim, Xiang A. Chen, Onkar Singh et al. · British Journal of Clinical Pharmacology · 2011 · 121 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

Hormone Receptor and c-ERBB2 Status in Distant Metastatic and Locally Recurrent Breast Cancer

Pushpalatha K.A. Idirisinghe, Aye Aye Thike, Poh Yian Cheok et al. · American Journal of Clinical Pathology · 2010 · 107 citations · Full text

Medicine, Oncology, Breast Oncology +15

Triple Negative Breast Cancer: Outcome Correlation With Immunohistochemical Detection of Basal Markers

Aye Aye Thike, Jabed Iqbal, Poh Yian Cheok et al. · The American Journal of Surgical Pathology · 2010 · 104 citations

Medicine, Oncology, Pathology +17

Predictors of Hand-Foot Syndrome and Pyridoxine for Prevention of Capecitabine–Induced Hand-Foot Syndrome

Yoon Sim Yap, Li‐Lian Kwok, Nicholas Syn et al. · JAMA Oncology · 2017 · 97 citations · Full text

Medicine, Oncology, Pharmacology +15